Blood protein may forecast success of gastric bypass
NCT ID NCT07241741
First seen Nov 21, 2025 · Last updated May 21, 2026 · Updated 28 times
Summary
This study tested whether a blood marker called PTX3 can predict how well people with obesity respond to gastric bypass surgery. Researchers followed 23 adults for 6 months after surgery, measuring weight loss, inflammation, and insulin resistance. The goal was to see if PTX3 levels before surgery could forecast these outcomes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
Explore the condition pages connected to this study.